ARVN
NASDAQ · Pharmaceuticals
Arvinas Inc
$6.55
-0.87 (-11.73%)
Open$7.43
Previous Close$7.42
Day High$7.43
Day Low$6.52
52W High$14.51
52W Low$6.52
Volume—
Avg Volume1.05M
Market Cap428.27M
P/E Ratio46.05
EPS$0.16
SectorPharmaceuticals
Analyst Ratings
Buy
23 analysts
Price Target
+911.0% upside
Current
$6.55
$6.55
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 242.17M | 192.26M | 233.97M |
| Net Income | -74,512,784 | -53,240,318 | 39.13M |
| Profit Margin | -30.8% | -29.2% | 16.7% |
| EBITDA | -106,518,758 | -80,337,265 | 67.61M |
| Free Cash Flow | — | — | 28.90M |
| Rev Growth | +26.0% | +26.0% | +1.6% |
| Debt/Equity | 0.00 | 0.00 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |